Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Don't want ads? Click here
Sponsored Content
Don't want ads? Click here

Pin to quick picksIQ-AI Share News (IQAI)

  • There is currently no data for IQAI

Watchlists are a member only feature

Login to your account

Timelines are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Feedback And Tissue Regenix Secure CE Marks

Mon, 01st Jun 2020 15:54

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Feedback PLC - medical imaging - Says its Bleepa imaging technology achieves CE mark, a European Union regulatory award. Adds mark gives healthcare providers confidence in Bleepa product.

----------

Tissue Regenix Group PLC - medical devices - Secures CE mark for OrthoPure XT tissue regeneration product.

----------

Arix Bioscience PLC - biotech investor - Says portfolio company Iterum Therapeutics PLC failed to meet the primary endpoint in study for Sulopenem as treatment for urinary tract infection.

----------

Hutchison China Meditech Ltd - pharmaceuticals - Plans to submit new drug application to US regulators for Surufatinib medication for cancer treatment. Planned start of new drug submission is late 2020. Notes US Food & Drug Administration in April gave Surufatinib fast track designation for development of neuroendocrine tumours in non-pancreatic and pancreatic medication.

----------

IQ-AI Ltd - medical software - Reports Imaging Biometrics subsidiary awarded USD2.6 million US grant in collaboration with Barrow Neurological Institute, the Mayo Clinic and the Medical College of Wisconsin. Funding to go towards research of brain tumour treatment response.

----------

LiDCO Group PLC - hemodynamic monitoring - Benefitted from increased demand in first quarter due to Covid-19 pandemic, but reports "exceptional conditions" have since eased somewhat. Adds that signs are suggesting number of elective surgeries returning to pre-pandemic levels and company's sales for May in-line with last year.

----------

EQTEC PLC - energy project technology provider - Strikes deal with lenders Altair Group Investment Ltd and Riverfort Global Opportunities PCC Ltd to extend maturity date of debts to June 30, 2021.

----------

Xeros Technology Group PLC - water filtration - Completes sale of Marken business after disposal was previously delayed by Covid-19 pandemic. Final cash consideration totalled GBP175,000.

----------

Gama Aviation PLC - aviation services - Awarded contract by UK Home Office to complete electronic devices testing on several emergency services aircrafts.

----------

Transense Technologies PLC - sensor systems - Extends exclusivity for collaboration agreement with Bridgestone Corp for installation of tyre monitoring systems.

----------

Amur Minerals Corp - nickel-copper sulphide explorer - Reports copper and nickel sulphide concentrates can be generated at Kun-Manie project, Russia. Says out of 6.0 million tonnes of ore processed per annum, copper concentrate of 39,300 tonnes is expected to be produced, at average grade of just over 23%.

----------

Independent Oil & Gas PLC - development and production - Awards core project phase 1 well management contract at UK southern North Sea assets to Petrofac.

----------

Atalaya Mining PLC - miner - Says regional government of Andalusia confirms through Spanish press that it has validated Atalaya's mining permits at Riotinto project.

----------

Star Phoenix Group Ltd - oilfield services - Grants LandOcean Energy Services Co Ltd extension to provide remaining USD459,970 cash in relation to sale of Range Resources Trinidad Ltd.

----------

Savannah Resources PLC - energy metals - Submits environmental impact assessment and mine plan for Mina do Barroso lithium project in Portugal.

----------

Rockfire Resources PLC - gold exploration - Says rock sampling results find new gold targets at Lighthouse tenement in Australia. Reports 15 rocks were collected from Cardigan Dam, with 47% returning gold values above 0.5 grammes per tonne.

----------

IronRidge Resources Ltd - mineral exploration - Says infill soil sampling at Zaranou gold project in Cote d'Ivoire confirms and enhances gold anomalies at asset.

----------

PowerHouse Energy Group PLC - hydrogen production - Not aware of any material reason for recent share price increase. Says continuing to manage operating costs and cash balances stand at GBP280,000, enough to meet outstanding cash burn until fourth quarter.

----------

AFC Energy PLC - hydrogen generation - Partners with Spanish infrastructure firm ACCIONA SA to test AFC's H-Power fuel cell platform which aims to decarbonise construction sites in Europe.

----------

Beowulf Mining PLC - mineral exploration - Says soil sampling at Vardar, Kosovo has found "extensive" gold anomaly over an area of roughly 1,4000 metres by 700 metres. Beowulf finalising plans for geophysical surveys once Covid-19 restrictions allow.

----------

Emmerson PLC - potash development - Completes feasibility study at Khemisset potash project, Morocco. Study finds posttax net present value with 8% discount of USD1.4 billion and pre-production costs of USD387 million.

----------

Danakali Ltd - potash mining - Agrees to extend deadline for tranche two of Colluli Sulphate of Potash project equity funding from Africa Finance Corp. Deadline extended to on or before November 31, in response to Covid-19 restrictions.

----------

Columbus Energy Resources PLC & Predator Oil & Gas Holdings PLC - oil and gas - Confirm start of phase 2 of carbon dioxide pilot project in Trinity Inniss field, Trinidad.

----------

Strategic Minerals PLC - minerals company - Says subsidiary Southern Minerals Group awarded USD21.9 million in damages over legal proceedings related to the Cobre mine.

----------

Trinity Exploration & Production PLC - exploration and production - Receives VAT bonds totalling USD2.8 million from Trinidad & Tobago government. Plans to sell bonds to local financial institution.

----------

Xtract Resources PLC - miner - Concludes deal to acquire Bushranger copper and gold project owner ProsepectOre Ltd for USD1.3 million in shares.

----------

Picton Property Income Ltd - property investor - Finalises USD50 million revolving credit facility to replace two existing loans which were due to expire in June 2021. The new facility has three-year initial term with option of two one-year extensions. Will incur interest at 150 basis points over LIBOR.

----------

Dods Group PLC - events - Says lender Barclays Bank agrees to waive all covenants for remainder of financial year in light of Covid-19 uncertainty.

----------

Warpaint London PLC - colour cosmetics producer - Agrees deal to stock its products at UK retail firm Wilko. From mid-September, roughly 100 Body Collection-branded productions will be stocked at 355 Wilko stores.

----------

Codemasters Group Holdings PLC - video game developer - Strikes licence agreement deal for exclusive rights to develop FIA World Rally Championship games and esports tournaments.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
2 May 2025 13:28

IN BRIEF: IQ-AI applies for breakthrough therapy designation for GaM

IQ-AI Ltd - London-based medical services company - Says subsidiary Imaging Biometrics LLC has applied for breakthrough therapy designation from the US Food & Drug Administration for its oral gallium maltolate therapy. Its phase 1 trial is evaluating the therapy as a potential treatment for adult patients with recurrent or refractory glioblastoma IDH-wildtype, with preliminary findings suggesting an overall survival of 34.1 months from initial diagnosis. This significantly exceeds the median survival of 14 to 15 months reported for patients undergoing standard treatment, though IQ-AI notes that caution is appropriate when considering the results due to the size of the trial population. The FDA is required to respond to IQ-AI's application within 60 days.

Read more
3 Feb 2025 19:22

IN BRIEF: IQ-AI amends distribution deal with Blackford Analysis

IQ-AI Ltd - London-based medical services company - Amends existing distribution agreement with artificial intelligence platform provider Blackford Analysis Ltd. The amendment adds IB Nimble, IB ASL, IB FTB, and IB FTB Express to the agreement, allowing Blackford to also sell these products to their global client base. Acquired by Bayer in early 2023, Blackford operates in the healthcare AI platform and solutions sphere.

Read more
22 Jan 2025 17:10

IN BRIEF: IQ-AI to take GaM to phase II study, flags AI capabilities

IQ-AI Ltd - London-based medical services company - Provides operations update focusing on artificial intelligence. Explains radiology leads the way in Food & Drug Administration approvals for AI-enabled products as the FDA has increased efforts to keep pace with the advancements in AI technology. The company believes its subsidiary, Imaging Biometrics LLC, is in a unique position to lead this transformation for neuro-oncology in 2025 and beyond. Points to the imminent release of the new version of IB Clinic; its FDA-cleared suite of quantitative imaging solutions will include the incorporation of an AI model, which will greatly improve diagnostic accuracy and speed. In addition, notes the first half of 2025 should mark the next release of IB Nimble with the functionality to view IB's AI-generated images and other images within the mobile app. Also, in 2025 we anticipate releasing a new product leveraging arterial spin labelling.

Read more
14 Oct 2024 10:05

IN BRIEF: Braveheart buys 30% stake in IQ-AI from Braveheart CEO Brown

IQ-AI Ltd - parent of Wisconsin-based Imaging Biometrics LLC, which provides quantitative imaging platforms and therapeutics for the diagnosis and treatment of patients - AIM-listed technology investor Braveheart Investment Group PLC buys a nearly 30% stake in IQ-AI from Braveheart Chief Executive Officer Trevor Brown. Braveheart buys 45.8 million IQ-AI shares from Brown at 1.1 pence per share, worth GBP503,372, and another 19.7 million shares owned by Brown's children at the same price, worth GBP216,203. The two purchases give Braveheart a 29.5% stake in IQ-AI. Braveheart on Friday says the related-party transaction is approved by its independent shareholders because the IQ-AI business fits Braveheart's investment strategy and the purchase is at "an attractive entry price".

Read more
16 Aug 2024 20:40

TRADING UPDATES: NetScientific loss narrows; Vinanz ups Bitcoin fleet

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and Wednesday and not separately reported by Alliance News:

Read more
25 Jun 2024 11:56

IN BRIEF: IQ-AI subsidiary opens expanded access programme

IQ-AI Ltd - London-based medical services company - US-based subsidiary Imaging Biometrics LLC says that US Food & Drug Administration has approved an expanded access programme for oral gallium maltolate. This EAP will run in parallel with the current phase 1 clinical trial being conducted at the Medical College of Wisconsin. Explains that "As the phase 1 trial concludes this fall and while the data is being compiled, eligible patients in the US will have the option of participating in the EAP."

Read more
14 Jun 2024 14:32

IQ-AI team begins defining phase 2 protocol for oral gallium maltolate

(Alliance News) - IQ-AI Ltd on Friday said the clinical team has started a phase 2 protocol for its oncology-focused drug oral gallium maltolate, which could be a therapeutic agent for cancer.

Read more
23 May 2024 21:08

TRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pact

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
20 May 2024 11:16

IQ-AI subsidiary gets second FDA rare paediatric disease designation

(Alliance News) - IQ-AI Ltd on Monday said its subsidiary, Imaging Biometrics LLC, received a second rare paediatric disease designation by the US Food & Drug Administration for its IB-003 lead drug candidate oral gallium maltolate.

Read more
17 May 2024 17:39

TRADING UPDATES: Ingenta trades in line; Triple Point Social NAV up

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
10 May 2024 15:14

IQ-AI subsidiary gets rare paediatric disease designation FDA

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary, Imaging Biometrics LLC, has been granted rare paediatric disease designation by the US Food & Drug Administration for its lead drug candidate, IB-003, or gallium maltolate for the treatment of ATRT.

Read more
2 May 2024 15:45

EARNINGS AND TRADING: Trident Royalties swings to profit

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Feb 2024 14:02

IN BRIEF: IQ-AI shares sink on discounted placing fundraise

IQ-AI Ltd - Medical services firm and parent company of Wisconsin-based healthcare imaging software firm Imaging Biometrics LLC - Announces placing to raise GBP300,000 gross proceeds via the issue of 20.0 million new shares at a price of 1.5p each. The issue price represents a discount of 32% to the company's Wednesday closing price of 2.2p. The placing includes a broker option for existing shareholders for up to 6.7 million new shares, which would raise an additional GBP100,000. Admission of the new placing and broker option shares is expected to occur on or around March 1.

Read more
9 Feb 2024 13:38

IQ-AI subsidiary asked by FDA to resubmit and modify application

(Alliance News) - IQ-AI Ltd on Friday said its subsidiary Imaging Biometric LLC will modify and resubmit its application to the US Food & Drug Administration.

Read more
2 Feb 2024 08:56

IN BRIEF: IQ-AI celebrates USD100,000 grant for subsidiary

IQ-AI Ltd - St Helier, Jersey-based medical services firm - Says that Imaging Biometrics LLC, a wholly-owned subsidiary of IQ-AI, has been given a USD100,000 grant by the Musella Foundation For Brain Tumor Research & Information Inc. Explains that the grant will help to support the launch of an intermediate group expanded access programme, which is focused on giving brain tumour patients access to oral gallium maltolate, outside of an ongoing Phase One clinical trial at the Medical College of Wisconsin. The grant will be used to facilitate the expanded access programme, including writing and submitting the study protocol, patient screening and on-boarding.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.